Chronic kidney disease (CKD) affects millions of people worldwide and remains a major health concern. Fortunately, recent advances in medicine and technology are bringing new hope for patients.
Some promising developments include:
GLP-1 receptor agonists such as semaglutide, which may help slow the progression of chronic kidney disease.
Finerenone, a targeted therapy that has shown benefits in protecting kidney function in people with diabetic kidney disease.
Iptacopan, an emerging treatment for IgA nephropathy that may reduce proteinuria and help preserve kidney function.
Imlifidase, a novel therapy that could improve kidney transplant opportunities for highly sensitized patients.
Ongoing research on artificial kidney and kidney-on-a-chip technologies are currently under investigation and may one day reduce dependence on dialysis.
As research continues to evolve, these innovations have the potential to transform kidney care and improve quality of life for many patients.
Which advancement do you think could have the greatest impact on kidney disease management in the future—new medications, transplant innovations, or artificial kidney technology?
Reference :
1.National Kidney Foundation National Kidney Foundation
MBH/DB